Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jack Su, MD
Baylor College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Children'S Medical Center Dallas, Center for Cancer and Blood Disorders
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Texas Health Science Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2009
- Primary completion
- 30 Aug 2015
- Completion
- 2 Oct 2017
- Last update posted
- 21 Jul 2021
- Registered enrollment
- 38
- Registry id
- NCT00879437
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.